Revision history of "Development of stabilised mixtures of fluorescentally labelled antibodies in a single test pack for flow cytometry" (Q12098)

20 March 2024

• curprev 14:0614:06, 20 March 2024‎ DG Regio talk contribs‎ 52,058 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.2637249037699931

15 January 2024

• curprev 15:0915:09, 15 January 2024‎ DG Regio talk contribs‎ 51,770 bytes +1,083‎ ‎Changed an Item

19 June 2023

• curprev 22:3922:39, 19 June 2023‎ Admin talk contribs‎ 50,687 bytes 0‎ BatchIngestion

11 June 2023

• curprev 12:5612:56, 11 June 2023‎ Admin talk contribs‎ 50,687 bytes +435‎ BatchIngestion

17 February 2023

• curprev 16:5816:58, 17 February 2023‎ DG Regio talk contribs‎ 50,252 bytes +1,888‎ ‎Changed an Item

2 July 2022

• curprev 18:5118:51, 2 July 2022‎ DG Regio talk contribs‎ 48,364 bytes +28,651‎ ‎Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et, cs, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et,

24 June 2022

• curprev 08:5008:50, 24 June 2022‎ Admin talk contribs‎ 19,713 bytes +427‎ ‎Undo revision 29357178 by DG Regio (talk) Tag: Undo
• curprev 08:4708:47, 24 June 2022‎ DG Regio talk contribs‎ 19,286 bytes −427‎ ‎Removed claim: beneficiary (P889): (Q197450), Removing claim

15 January 2022

• curprev 03:1903:19, 15 January 2022‎ DG Regio talk contribs‎ 19,713 bytes +1,569‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

14 January 2022

• curprev 02:2102:21, 14 January 2022‎ DG Regio talk contribs‎ 18,144 bytes +1,529‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

12 December 2021

• curprev 14:2514:25, 12 December 2021‎ DG Regio talk contribs‎ 16,615 bytes +1,542‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

2 December 2021

• curprev 08:0308:03, 2 December 2021‎ DG Regio talk contribs‎ 15,073 bytes +1,365‎ ‎Created claim: summary (P836): Ziel des Projekts ist es, die Kapazitäten des eigenen F & E-Unternehmens Exbio Praha, a.s. im Bereich der stabilisierten Mischungen fluoreszierender Antikörper in Einzeltestverpackungen für die Durchflusszytometrie zu erhöhen. Der Ausbau von VIK wird die Position des Unternehmens im Welthandel mit monoklonalen Antikörpern, ihren Derivaten und Diagnosekits für die klinische Diagnostik im Gesundheitswesen stärken und eine weitere Erweiterung und D...
• curprev 08:0308:03, 2 December 2021‎ DG Regio talk contribs‎ 13,708 bytes +173‎ ‎Changed label, description and/or aliases in de: translated_label

28 November 2021

• curprev 09:2909:29, 28 November 2021‎ DG Regio talk contribs‎ 13,535 bytes +1,386‎ ‎Created claim: summary (P836): L’objectif du projet est d’accroître les capacités de sa propre société de R & D Exbio Praha, a.s. dans le domaine des mélanges stabilisés d’anticorps marqués fluorescents dans des emballages à essai unique pour la cytométrie de flux. L’expansion de VIK renforcera la position de l’entreprise sur le commerce mondial des anticorps monoclonaux, de leurs dérivés et des kits de diagnostic pour le diagnostic clinique dans les soins de santé et permett...
• curprev 09:2909:29, 28 November 2021‎ DG Regio talk contribs‎ 12,149 bytes +197‎ ‎Changed label, description and/or aliases in fr: translated_label

27 December 2020

• curprev 16:2116:21, 27 December 2020‎ DG Regio talk contribs‎ 11,952 bytes −4‎ ‎Changed an Item: Change because item Q214255 was merged with Q4859

28 October 2020

• curprev 17:0317:03, 28 October 2020‎ DG Regio talk contribs‎ 11,956 bytes −406‎ ‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement
• curprev 17:0317:03, 28 October 2020‎ DG Regio talk contribs‎ 12,362 bytes −39‎ ‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair

22 October 2020

• curprev 15:1115:11, 22 October 2020‎ DG Regio talk contribs‎ 12,401 bytes +1,299‎ ‎Created claim: summary (P836): The aim of the project is to increase the R & D capacity of Exbio Praha, a.s. in the area of stabilised mixtures of fluorescence-labelled antibodies in a single-test packaging for flow cytometry. The expansion of VIK will strengthen the company’s position in the world trade in monoclonal antibodies, their derivatives and diagnostic kits for clinical diagnosis in health care and will allow further expansion and diversification of products mainly...
• curprev 15:1115:11, 22 October 2020‎ DG Regio talk contribs‎ 11,102 bytes −854‎ ‎Removed claim: summary (P836): The objective of the project is to increase the own R & D capacities of EXBIO Praha, a.s. in the area of stabilised mixtures of fluorescent antibody in single-test packages for flow cytometry. The extension of the VIK will strengthen the company’s position in world trade in monoclonal antibodies, their derivatives and diagnostic kits for clinical diagnosis in the health sector and allow for the further expansion and diversification of products...
• curprev 07:2707:27, 22 October 2020‎ DG Regio talk contribs‎ 11,956 bytes +174‎ ‎Changed label, description and/or aliases in 1 language: translated_label
• curprev 07:2707:27, 22 October 2020‎ DG Regio talk contribs‎ 11,782 bytes −161‎ ‎Changed label, description and/or aliases in 1 language: remove_english_label

15 July 2020

• curprev 20:0220:02, 15 July 2020‎ DG Regio talk contribs‎ 11,943 bytes +429‎ ‎Changed an Item

6 June 2020

• curprev 20:5020:50, 6 June 2020‎ DG Regio talk contribs‎ 11,514 bytes +431‎ ‎Changed an Item

25 March 2020

• curprev 18:0318:03, 25 March 2020‎ DG Regio talk contribs‎ 11,083 bytes +431‎ ‎Changed an Item

26 February 2020

• curprev 07:5007:50, 26 February 2020‎ DG Regio talk contribs‎ 10,652 bytes +854‎ ‎Created claim: summary (P836): The objective of the project is to increase the own R & D capacities of EXBIO Praha, a.s. in the area of stabilised mixtures of fluorescent antibody in single-test packages for flow cytometry. The extension of the VIK will strengthen the company’s position in world trade in monoclonal antibodies, their derivatives and diagnostic kits for clinical diagnosis in the health sector and allow for the further expansion and diversification of products m...

17 February 2020

• curprev 19:0619:06, 17 February 2020‎ DG Regio talk contribs‎ 9,798 bytes +161‎ ‎Changed an Item: Label in wikidata changed

12 February 2020

• curprev 02:5002:50, 12 February 2020‎ DG Regio talk contribs‎ 9,637 bytes +3,164‎ ‎Changed an Item
• curprev 02:5002:50, 12 February 2020‎ DG Regio talk contribs‎ 6,473 bytes −3,164‎ ‎Removed claims

6 February 2020

• curprev 12:1212:12, 6 February 2020‎ DG Regio talk contribs‎ 9,637 bytes +823‎ ‎Changed an Item

30 January 2020

• curprev 10:4610:46, 30 January 2020‎ DG Regio talk contribs‎ 8,814 bytes +427‎ ‎Changed an Item

28 January 2020

• curprev 13:4113:41, 28 January 2020‎ DG Regio talk contribs‎ 8,387 bytes +427‎ ‎Changed an Item

16 January 2020

• curprev 17:2217:22, 16 January 2020‎ DG Regio talk contribs‎ 7,960 bytes +508‎ ‎Changed an Item

10 January 2020

• curprev 19:2319:23, 10 January 2020‎ DG Regio talk contribs‎ 7,452 bytes +7,452‎ ‎Created a new Item